|Bid||51.52 x 1400|
|Ask||55.95 x 800|
|Day's Range||53.49 - 55.69|
|52 Week Range||17.51 - 93.94|
|Beta (5Y Monthly)||1.93|
|PE Ratio (TTM)||110.37|
|Earnings Date||Aug 05, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||79.11|
The latest analyst coverage could presage a bad day for Denali Therapeutics Inc. ( NASDAQ:DNLI ), with the analysts...
Denali (DNLI) posts a wider-than-expected loss in the first quarter of 2021 due to higher R&D costs.
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -56.76% and -72.76%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?